Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment. [Carta] (2018)
- Autor:
- Autor USP: EVORA, PAULO ROBERTO BARBOSA - FMRP
- Unidade: FMRP
- DOI: 10.1186/s13054-018-2024-y
- Subjects: RESISTÊNCIA VASCULAR; CHOQUE SÉPTICO
- Language: Inglês
- Imprenta:
- Source:
- Título: Critical Care
- ISSN: 1364-8535
- Volume/Número/Paginação/Ano: v. 22, art. 104, 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
EVORA, Paulo Roberto Barbosa. Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment. [Carta]. Critical Care. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13054-018-2024-y. Acesso em: 28 jan. 2026. , 2018 -
APA
Evora, P. R. B. (2018). Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment. [Carta]. Critical Care. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1186/s13054-018-2024-y -
NLM
Evora PRB. Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment. [Carta] [Internet]. Critical Care. 2018 ; 22[citado 2026 jan. 28 ] Available from: https://doi.org/10.1186/s13054-018-2024-y -
Vancouver
Evora PRB. Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment. [Carta] [Internet]. Critical Care. 2018 ; 22[citado 2026 jan. 28 ] Available from: https://doi.org/10.1186/s13054-018-2024-y - Methylene blue and cardiovascular collapse. [Carta]
- Possible advances in vasopressors and inotropes support in shock. [Carta]
- Comparisons of the release of vasodilator substances from left and right cardiac chambers of the isolated perfused rabbit heart: implications for intraventricular thrombus formation
- Endothelium dysfunction classification: why is it still an open discussion?.[Carta]
- Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue
- Budd-chiari syndrome in a 25-year-old woman with behçet's disease: a case report and review of the literature
- Mitral stenosis acute pulmonary edema and rheumatic fever pneumonitis: a hypothesis to an old enigma [carta]
- Letter by Gomes and Evora regarding article, "Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome" [Carta]
- Effect of the chronic metabolic acidosis on rat thoracic aorta reactivity
- Methylene blue is a guanylate cyclase inhibitor that does not interfere with nitric oxide synthesis. [Carta]
Informações sobre o DOI: 10.1186/s13054-018-2024-y (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002938483.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
